125 related articles for article (PubMed ID: 31606407)
1. Intracerebroventricular injection of deltamethrin increases locomotion activity and causes spatial working memory and dopaminergic pathway impairment in rats.
Souza MF; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Freire MAM; Marchioro M; Santos JR
Brain Res Bull; 2020 Jan; 154():1-8. PubMed ID: 31606407
[TBL] [Abstract][Full Text] [Related]
2. Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats.
Souza MF; Freire MAM; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Leal PC; Engelberth RCGJ; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Brain Res Bull; 2018 Sep; 142():297-303. PubMed ID: 30118749
[TBL] [Abstract][Full Text] [Related]
3. Motor, memory, and anxiety-like behavioral impairments associated with brain-derived neurotrophic factor and dopaminergic imbalance after inhalational exposure to deltamethrin.
Souza MF; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Santos ER; Almeida-Souza TH; Melo JEC; Franco HS; Silva RS; Pereira-Filho EA; Freire MAM; Santos JR
Brain Res Bull; 2022 Apr; 181():55-64. PubMed ID: 35041849
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
Abbaoui A; Chatoui H; El Hiba O; Gamrani H
Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
[TBL] [Abstract][Full Text] [Related]
6. Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
Melo JEC; Santos TFO; Santos RS; Franco HS; Monteiro MCN; Bispo JMM; Mendonça MS; Ribeiro AM; Silva RH; Gois AM; Marchioro M; Lins LCRF; Santos JR
J Chem Neuroanat; 2022 Nov; 125():102162. PubMed ID: 36115503
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors.
Hall H; Jewett M; Landeck N; Nilsson N; Schagerlöf U; Leanza G; Kirik D
PLoS One; 2013; 8(5):e64844. PubMed ID: 23705016
[TBL] [Abstract][Full Text] [Related]
8. Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats.
Boekhoudt L; Omrani A; Luijendijk MC; Wolterink-Donselaar IG; Wijbrans EC; van der Plasse G; Adan RA
Eur Neuropsychopharmacol; 2016 Nov; 26(11):1784-1793. PubMed ID: 27712862
[TBL] [Abstract][Full Text] [Related]
9. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study.
Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F
Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689
[TBL] [Abstract][Full Text] [Related]
10. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
Ramírez-García G; Palafox-Sánchez V; Limón ID
Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice.
El Fari R; Abbaoui A; Bourziq A; Zroudi M; Draoui A; El Khiat A; Belkouch M; Elgot A; Gamrani H
J Chem Neuroanat; 2019 Dec; 102():101686. PubMed ID: 31562917
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
13. Sensory-motor performance after acute glutathione depletion by L-buthionine sulfoximine injection into substantia nigra pars compacta.
Díaz-Hung ML; Blanco L; Pavón N; León R; Estupiñan B; Orta E; Martínez K; Fernández I
Behav Brain Res; 2014 Sep; 271():286-93. PubMed ID: 24912031
[TBL] [Abstract][Full Text] [Related]
14. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M
Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222
[TBL] [Abstract][Full Text] [Related]
15. Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model.
Xu DA; DeYoung TP; Kondoleon NP; Eckenhoff RG; Eckenhoff MF
Anesth Analg; 2021 Nov; 133(5):1140-1151. PubMed ID: 34673725
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats.
Brambilla Bagatini P; Xavier LL; Neves L; Saur L; Barbosa S; Baptista PP; Augustin OA; Nunes de Senna P; Mestriner RG; Souto AA; Achaval M
Brain Res; 2014 Dec; 1592():101-12. PubMed ID: 25446006
[TBL] [Abstract][Full Text] [Related]
18. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
eNeuro; 2017; 4(1):. PubMed ID: 28303260
[TBL] [Abstract][Full Text] [Related]
20. The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration.
Apóstol Del Rosal GD; Limón ID; Martínez I; Patricio-Martínez A
Neurotox Res; 2021 Oct; 39(5):1405-1417. PubMed ID: 34279823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
